Mouse Anti-CD302 Recombinant Antibody (CBT3819) (V2LY-0625-LY1147)

Brown, R. J., Tegtmeyer, B., Sheldon, J., Khera, T., Anggakusuma, Todt, D., ... & Pietschmann, T. (2020). Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice. Science advances, 6(45), eabd3233.

Kok, C. H., Liu, L., Yeung, D. T., Saunders, V. A., Dang, P., & Hughes, T. P. (2019). A Combination of CD302 gene Expression and 3-Months BCR-ABL1 Level Predicts Inferior Achievement of Deep Molecular Response in CP-CML Patients Treated with Imatinib.

Lo, T. H., Abadir, E., Gasiorowski, R. E., Kabani, K., Ramesh, M., Orellana, D., ... & Clark, G. J. (2019). Examination of CD302 as a potential therapeutic target for acute myeloid leukemia. Plos one, 14(5), e0216368.

Alaterre, E., Raimbault, S., Goldschmidt, H., Bouhya, S., Requirand, G., Robert, N., ... & Moreaux, J. (2017). CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma. Oncotarget, 8(58), 98931.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols